EUVIMEDEUVIMED entdecken
Crossref

IL‐21 collaborates with anti‐TIGIT to restore NK cell function in chronic HBV infection

Libo Tang, Quanrun Li, Liang Chen, Xiaowei Li, Shuqin Gu, Weiying He, Qingqing Pan, Liping Wang, Jianru Sun, Xuan Yi, Yongyin Li iD

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.29142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Libo Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, N…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Available therapies for chronic hepatitis B virus (HBV) infection are not satisfying, and interleukin‐21 (IL‐21) and checkpoint inhibitors are potential therapeutic options. However, the mechanism underlying IL‐21 and checkpoint inhibitors in treating chronic HBV infection is unclear. To explore whether IL‐21 and checkpoint inhibitors promote HBV clearance by modulating the function of natural killer (NK) cells, we measured the phenotypes and functions of NK cells in chronic HBV‐infected patients and healthy controls on mRNA and protein levels. We found that chronic HBV infection disturbed the transcriptome of NK cells, including decreased expression of KLRK1, TIGIT, GZMA, PRF1 , and increased expression of CD69 . We also observed altered phenotypes and functions of NK cells in chronic HBV‐infected patients, characterized by decreased NKG2D expression, increased TIGIT expression and impaired interferon‐gamma (IFN‐γ), tumor necrosis factor‐alpha (TNF‐α) production. Furthermore, these alterations cannot be restored by telbivudine treatment but can be partially restored by IL‐21 and anti‐TIGIT stimulation. IL‐21 upregulated the expression of activating receptor CD16, CD69, and NKG2D on NK cells, enhanced IFN‐γ production, cytolysis, and proliferation of NK cells, while anti‐TIGIT promoted IFN‐γ production in CD56 dim subset exclusively in chronic HBV infected patients. Additionally, IL‐21 was indispensable for anti‐TIGIT in HBsAg clearance in mice bearing HBV. It enhanced IFN‐γ production in splenic NK cells rather than intrahepatic NK cells, indicating a brand‐new mechanism of IL‐21 in HBV clearance when combined with anti‐TIGIT. Overall, our findings contribute to the design of immunotherapy through enhancing the antiviral efficacy of NK cells in chronic HBV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicAnimalsHumansMiceHepatitis B virusKiller Cells, NaturalNK Cell Lectin-Like Receptor Subfamily KReceptors, ImmunologicInterleukin-21

Stichwörter der Autor:innen

NK cellsTIGITchronic hepatitis B virus infectioninterleukin-21

Substanzen

Interleukin-21NK Cell Lectin-Like Receptor Subfamily KReceptors, ImmunologicTIGIT protein, humanT cell Ig and ITIM domain protein, mouse

Autor:innen und Institutionen

  • State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Key Infectious Diseases Laboratory (Preparatory) of Yunnan Provincial Department of Education, Department of Infectious Diseases, School of Clinical Medicine, The First Affiliated Yunnan Provincial Clinical Medical Cent…
  • Department of Infectious Diseases, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China.
  • Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China.

ORCID-Profile: Yongyin Li

Zitieren

APA

Tang, L., Li, Q., Chen, L., Li, X., Gu, S., He, W., Pan, Q., Wang, L., Sun, J., Yi, X., & Li, Y. (2023). IL‐21 collaborates with anti‐TIGIT to restore NK cell function in chronic HBV infection. Journal of Medical Virology. https://doi.org/10.1002/jmv.29142

Vancouver

Tang L, Li Q, Chen L, Li X, Gu S, He W, et al. IL‐21 collaborates with anti‐TIGIT to restore NK cell function in chronic HBV infection. Journal of Medical Virology. 2023. doi:10.1002/jmv.29142

BibTeX
@article{Tang2023,
  author = {Tang, Libo and Li, Quanrun and Chen, Liang and Li, Xiaowei and Gu, Shuqin and He, Weiying and Pan, Qingqing and Wang, Liping and Sun, Jianru and Yi, Xuan and Li, Yongyin},
  title = {IL‐21 collaborates with anti‐TIGIT to restore NK cell function in chronic HBV infection},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.29142}
}
Kostenlos starten →